These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33811524)

  • 1. New Approaches to the Prevention and Treatment of Viral Diseases.
    Pronin AV; Narovlyansky AN; Sanin AV
    Arch Immunol Ther Exp (Warsz); 2021 Apr; 69(1):10. PubMed ID: 33811524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosprenyl: a novel drug with antiviral and immunomodulatory activity.
    Danilov LL; Maltsev SD; Deyeva AV; Narovlyansky AN; Sanin AV; Ozherelkov SV; Pronin AV
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):395-400. PubMed ID: 9017158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral and immunomodulating activity of polyprenyl phosphates in viral infections].
    Vasil'ev AN; Ozherelkov SV; Kozlov vV; Pronin AV; Sanin AV; Parfenova TM; Izmest'eva AV; Amchenkova AM; Kozhevnikova TN; Stepanova TN; Narovlianskiĭ AN
    Antibiot Khimioter; 2008; 53(3-4):3-8. PubMed ID: 18942418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future prospects for antiviral agents and new approaches.
    Galasso GJ
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():127-36. PubMed ID: 6208182
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.
    Gale M; Katze MG
    Pharmacol Ther; 1998 Apr; 78(1):29-46. PubMed ID: 9593328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of polyprenyl phosphates in the experimental genital herpes model].
    Narovlyansky AN; Ivanova AM; Shevlyagina NV; Didenko LV; Borovaya TG; Izmest'eva AV; Sanin AV; Pronin AV; Ershov FI
    Vopr Virusol; 2015; 60(4):9-13. PubMed ID: 26665428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review.
    Seo DJ; Choi C
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatched double-stranded RNA: polyI:polyC12U.
    Adis Editorial
    Drugs R D; 2004; 5(5):297-304. PubMed ID: 15357629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.
    Bordier BB; Ohkanda J; Liu P; Lee SY; Salazar FH; Marion PL; Ohashi K; Meuse L; Kay MA; Casey JL; Sebti SM; Hamilton AD; Glenn JS
    J Clin Invest; 2003 Aug; 112(3):407-14. PubMed ID: 12897208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a prenylation inhibitor as a novel antiviral agent.
    Glenn JS; Marsters JC; Greenberg HB
    J Virol; 1998 Nov; 72(11):9303-6. PubMed ID: 9765479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenylation of HDAg and antiviral drug development.
    Glenn JS
    Curr Top Microbiol Immunol; 2006; 307():133-49. PubMed ID: 16903224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals and antiviral strategies.
    De Clercq E
    Nat Rev Microbiol; 2004 Sep; 2(9):704-20. PubMed ID: 15372081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species as potential antiviral targets.
    Sander WJ; Fourie C; Sabiu S; O'Neill FH; Pohl CH; O'Neill HG
    Rev Med Virol; 2022 Jan; 32(1):e2240. PubMed ID: 33949029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral activity of polyprenylphosphates in experimental infection caused by hepatitis C virus in vitro].
    Narovlianskiĭ AN; Deriabin PG; Sedov AM; Sanin AV; Pronin AV
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):81-4. PubMed ID: 23163044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.
    Lobaina Y; Perera Y
    Infect Disord Drug Targets; 2019; 19(1):2-16. PubMed ID: 29589547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies.
    Ghafouri-Fard S; Hussen BM; Jamal HH; Taheri M; Sharifi G
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA control of interferons and interferon induced anti-viral activity.
    Sedger LM
    Mol Immunol; 2013 Dec; 56(4):781-93. PubMed ID: 23962477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of viral particles and their replication productions with the plasma membranes of infected cells. New approaches to the chemotherapy of viral infections].
    Zaĭdes VM; Zhdanov VM
    Vopr Virusol; 1981; (4):388-94. PubMed ID: 7029907
    [No Abstract]   [Full Text] [Related]  

  • 19. Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.
    Gargan S; Stevenson NJ
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral drugs for viruses other than human immunodeficiency virus.
    Razonable RR
    Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.